PRELUDE THERAPEUTICS INC shareholders Q3 2023

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 61 filers reported holding PRELUDE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 6.00 and the average weighting 0.0%.

PRELUDE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MANUFACTURERS LIFE INSURANCE COMPANY, THE 70,165$216,8100.00%
Legal & General Group Plc 962$2,9730.00%
GEODE CAPITAL MANAGEMENT, LLC 331,100$1,023,2350.00%
STATE STREET CORP 187,209$578,4760.00%
MILLENNIUM MANAGEMENT LLC 63,867$197,3490.00%
PRICE T ROWE ASSOCIATES INC /MD/ 1,066,858$3,2980.00%
NEW YORK STATE COMMON RETIREMENT FUND 20,149$620.00%
NISA INVESTMENT ADVISORS, LLC 37$1140.00%
DEUTSCHE BANK AG\ 446$1,3780.00%
CITIGROUP INC 526$1,6250.00%
HSBC HOLDINGS PLC 23,198$70,7540.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 123,031$380,1660.00%
GOLDMAN SACHS GROUP INC 67,688$209,1560.00%
MORGAN STANLEY 244,470$755,4110.00%
ACADIAN ASSET MANAGEMENT LLC 7,023$210.00%
AMALGAMATED BANK 964$30.00%
BlackRock Inc. 1,068,434$3,301,4600.00%
Bank of New York Mellon Corp 32,882$101,6050.00%
Citadel Advisors 200$6180.00%
Citadel Advisors 1,200$3,7080.00%
External links

This page lists PRELUDE THERAPEUTICS INC's shareholders in Q3 2023. To view PRELUDE THERAPEUTICS INC's shareholder history, click here.